Sort
50,496 grants matching “lung cancer”
Commercializing Praedicare Dx TM platform for guiding cancer treatments
$1,000,000Michael H Cardone · Eutropics Pharmaceuticals, Inc. · R44 · FY2019 · CA
OTHER FUNCTIONS: TOPIC 287, PHASE II "NANOTECHNOLOGY SENSING PLATFORMS"
$1,000,000Swapnajit Chakravarty · Omega Optics, Inc. · N44 · FY2012 · CA
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
$1,000,000Gail E Sonenshein · Adecto Pharmaceuticals, Inc. · R44 · FY2018 · CA
Programmable Individualized NRT Merged With Digital Behavioral Support
$1,000,000Alan Joel Levy · Chrono Therapeutics, Inc. · R44 · FY2018 · CA
Development of GPER Agonists as Cancer Therapeutics
$1,000,000Tina Garyantes · Linnaeus Therapeutics, Llc · R44 · FY2020 · CA
eNamptorTM: A Humanized mAb To Reduce the Severity of Radiation Pneumonitis and Fibrosis
$1,000,000Joe G. N. Garcia · Aqualung Therapeutics Corp. · R42 · FY2021 · HL
PredicTOR: predicting patient response to mTOR pathway inhibitors prior to treatm
$1,000,000Michael Lebowitz · 20/20 Genesystems, Inc. · R44 · FY2011 · CA
Tailored NRT Integrated with Smartphone Behavioral Support
$1,000,000Alan Joel Levy · Chrono Therapeutics, Inc. · R44 · FY2017 · CA
Development of Deep Mutational Scanning with Duplex Sequencing (DMS-DS) for anti-cancer drug evaluation and administration
$1,000,000Joshua Reynolds · Atlas Biologics, Llc · R44 · FY2025 · CA
Development of a novel accurate therapy for multiple sclerosis
$1,000,000Gaddiel Galarza-Munoz · Autoimmunity Biologic Solutions, Inc. · R42 · FY2022 · AI
First in Human Phase I/II clinical trial of ONC-392: Preserving CTLA-4 immune tolerance checkpoint for safer and more effective cancer immunotherapy
$1,000,000Pan Zheng · Oncoc4, Inc. · R44 · FY2022 · CA
Studying a Human Stem Cell Disease Using iPS Technology
$1,000,000Steven E Artandi · Stanford University · RC1 · FY2010 · HL
Cobre for Signal Transduction and Cancer
$1,000,000Laura F Gibson · West Virginia University · P20 · FY2009 · RR
Tailored NRT Integrated with Smartphone Behavioral Support
$1,000,000Alan Joel Levy · Chrono Therapeutics, Inc. · R44 · FY2016 · CA
Rapid 3D Whole-Slide Digitization of Thick Cytopathology Slides with a Gigapixel Microscope
$1,000,000Mark Harfouche · Ramona Optics, Inc. · R44 · FY2022 · CA
University of New Mexico Cancer Center Support Grant
$1,000,000Cheryl L Willman · University Of New Mexico Health Scis Ctr · P30 · FY2020 · CA
Patient tailored near real-time image-based treatment for interstitial PDT of Inoperable Cancer with Airway Obstruction - Phase IIa
$1,000,000Mary Potasek · Simphotek, Inc. · R44 · FY2022 · CA
Exosomal Drug Delivery
$1,000,000Wendy A Spencer · 3p Biotechnologies, Inc. · R44 · FY2018 · CA
SIRPant Technology for anti-Cancer Immunity
$1,000,000Nathanael McCurley · Sirpant Immunotherapeutics, Inc. · R42 · FY2023 · CA
Rapid 3D Whole-Slide Digitization of Thick Cytopathology Slides with a Gigapixel Microscope
$1,000,000Mark Harfouche · Ramona Optics, Inc. · R44 · FY2021 · CA
MicroRNA-based Radiation Biodosimeter (MiRAD) Phase II
$1,000,000Claude J. Rogers · Chromologic, Llc · R44 · FY2019 · AI
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
$1,000,000Gail E Sonenshein · Adecto Pharmaceuticals, Inc. · R44 · FY2019 · CA
Mitigation of Radiation Pneumonopathy By Lignan Action
$1,000,000Melpo Christofidou-Solomidou · University Of Pennsylvania · RC1 · FY2010 · AI
Development of GPER Agonists as Cancer Therapeutics
$1,000,000Tina Garyantes · Linnaeus Therapeutics, Llc · R44 · FY2019 · CA
Moffitt Cancer Center Support Grant
$1,000,000Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2016 · CA